Stock 688098 SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Shen Lian Biomedical Corporation

Equities

688098

CNE100003P17

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
5.12 CNY +0.39% Intraday chart for Shanghai Shen Lian Biomedical Corporation -3.40% -31.55%
May. 06 Shen Lian Biomedical Gets Certificate for Swine Fever Vaccine; Shares Up 3% MT
Apr. 26 Shanghai Shen Lian Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 6,871 6,592 4,534 3,261 3,072
Enterprise Value (EV) 1 6,213 6,005 4,066 2,903 2,866
P/E ratio 79.9 x 51.9 x 40.9 x 52.9 x 93.5 x
Yield 0.48% 0.62% - 1.01% 0.47%
Capitalization / Revenue 27.1 x 19.5 x 12.6 x 9.92 x 10.2 x
EV / Revenue 24.5 x 17.8 x 11.3 x 8.83 x 9.5 x
EV / EBITDA 70 x 41.2 x 26.4 x 23.4 x 31.6 x
EV / FCF -58 x -49.4 x -32.2 x -29.4 x -25.3 x
FCF Yield -1.73% -2.03% -3.11% -3.4% -3.95%
Price to Book 5.36 x 4.72 x 2.83 x 2.18 x 2.06 x
Nbr of stocks (in thousands) 409,700 409,700 410,644 410,644 410,644
Reference price 2 16.77 16.09 11.04 7.940 7.480
Announcement Date 4/23/20 4/25/21 4/26/23 4/26/23 4/26/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 275.1 253.8 337.7 358.4 328.6 301.5
EBITDA 1 103.5 88.78 145.6 153.9 124.3 90.67
EBIT 1 91.61 73.82 124.9 110.3 67.56 27.7
Operating Margin 33.3% 29.08% 36.98% 30.77% 20.56% 9.19%
Earnings before Tax (EBT) 1 101.3 90.84 150 126 74.55 36.27
Net income 1 87.58 77.96 129.5 110.2 61.1 31.52
Net margin 31.83% 30.71% 38.35% 30.75% 18.59% 10.45%
EPS 2 0.2600 0.2100 0.3100 0.2700 0.1500 0.0800
Free Cash Flow 1 51.37 -107.2 -121.6 -126.3 -98.76 -113.1
FCF margin 18.67% -42.23% -36.01% -35.25% -30.06% -37.51%
FCF Conversion (EBITDA) 49.63% - - - - -
FCF Conversion (Net income) 58.66% - - - - -
Dividend per Share 2 0.0800 0.0800 0.1000 - 0.0800 0.0350
Announcement Date 8/9/19 4/23/20 4/25/21 4/26/23 4/26/23 4/26/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 354 658 587 468 357 206
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 51.4 -107 -122 -126 -98.8 -113
ROE (net income / shareholders' equity) 12.7% 7.38% 9.66% 7.28% 4.11% 1.99%
ROA (Net income/ Total Assets) 6.72% 3.75% 5.27% 4.43% 2.64% 1.08%
Assets 1 1,304 2,079 2,458 2,488 2,318 2,912
Book Value Per Share 2 2.310 3.130 3.410 3.900 3.650 3.630
Cash Flow per Share 2 1.070 0.3800 0.2800 0.1200 0.1300 0.1100
Capex 1 78.8 104 164 188 93.1 130
Capex / Sales 28.64% 41.01% 48.43% 52.5% 28.34% 43%
Announcement Date 8/9/19 4/23/20 4/25/21 4/26/23 4/26/23 4/26/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

1st Jan change Capi.
SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION Stock Shanghai Shen Lian Biomedical Corporation
-31.55% 290M
ZOETIS INC. Stock Zoetis Inc.
-14.09% 77.37B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
+18.66% 8.74B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+23.75% 3.67B
VIRBAC Stock Virbac
-0.42% 3.25B
VIMIAN GROUP AB Stock Vimian Group AB
+18.07% 1.73B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-16.99% 1.38B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-26.05% 1.24B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-17.86% 1.07B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. Stock Tianjin Ringpu Bio-Technology Co.,Ltd.
-6.77% 976M
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. 688098 Stock
  4. Financials Shanghai Shen Lian Biomedical Corporation